The dawn of a new era of targeted therapies for heart failure with preserved ejection fraction (HFpEF)

Hypertens Res. 2022 Jan;45(1):164-166. doi: 10.1038/s41440-021-00799-8. Epub 2021 Nov 24.

Authors

Kenji Harada¹, Kazuomi Kario²

Affiliations

¹ Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan. haradak@jichi.ac.jp.
² Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.

PMID: 34819620
DOI: 10.1038/s41440-021-00799-8

No abstract available

Publication types

Editorial
Comment

MeSH terms

Heart Failure* / drug therapy
Humans
Stroke Volume
Ventricular Function, Left